Papers matching “rituximab” in Systemic Lupus Erythematosus Research 21
Not finding it? Sign in to also search OpenAlex live.
-
P127 Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory SLE: two year results rituximab and belimumab combination for severe SLE2020 Poster presentations conference-abstract Medicine Systemic Lupus Erythematosus Research Open access
Tineke Kraaij, Eline J. Arends, Laura S. van Dam, Sylvia W.A. Kamerling, Paul L. A. van Daele, Obbo W Bredewold, +7 more
3citations -
POS0775 RITUXIMAB ASSOCIATED WITH A DECREASED RISK OF LUPUS NEPHRITIS FLARE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Systemic Lupus Erythematosus Research Open access
T.J. Lee, Ting‐Yuan Lan, Ioannis; https://orcid.org/0000-0002-4875-5395 Parodis, Cheng‐Hsien Lu, Chen‐Yang Shen, Kejun Li, +1 more
1citations -
#2772 Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report2025 Nephrology Dialysis Transplantation article Medicine Systemic Lupus Erythematosus Research Open access
Mieke van Schaik, Eline J. Arends, Marjolein J.A.L. Wetzels, Tineke Kraaij, Sandra W. van der Kooij, Sylvia W.A. Kamerling, +5 more
0citations -
ABS0517 LONG-TERM SAFETY AND EFFICACY OF THE COMBINATION OF BELIMUMAB AND RITUXIMAB IN THE TREATMENT OF SEVERE AND REFRACTORY SLE: A PRELIMINARY REPORT2025 Annals of the Rheumatic Diseases conference-abstract Medicine Systemic Lupus Erythematosus Research Open access
Mieke van Schaik, E. Arends, Marjolein J.A.L. Wetzels, Sylvia W.A. Kamerling, Tom W. J. Huizinga, Robbert J Goekoop, +2 more
0citations -
Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results2020 Nephrology Dialysis Transplantation article Medicine Systemic Lupus Erythematosus Research Open access
Tineke Kraaij, Eline J. Arends, Laura S. van Dam, Sylvia W.A. Kamerling, Paul L. A. van Daele, Obbo W Bredewold, +7 more
90citations -
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study2024 Annals of the Rheumatic Diseases article Medicine Systemic Lupus Erythematosus Research Open access
Cynthia B. Aranow, Cornelia F Allaart, Zahir Amoura, Ian N Bruce, Patricia C. Cagnoli, Walter Winn Chatham, +15 more
55citations -
POS0003 RITUXIMAB THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS – TRANSIENT EFFECTS ON AGE ASSOCIATED B-CELLS2021 Annals of the Rheumatic Diseases conference-abstract Medicine Systemic Lupus Erythematosus Research
Francesca Faustini, Natalie Sippl, Ragnhild Stålesen, Karine Chemin, Iva Gunnarsson, Vivianne Malmström
3citations -
OP0281 PHARMACODYNAMIC EFFECT OF SEQUENTIAL BELIMUMAB (BEL) AND RITUXIMAB (RTX) THERAPY IN PATIENTS (PTS) WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): THE PHASE 3, RANDOMISED, PLACEBO-CONTROLLED BLISS-BELIEVE STUDY2022 Annals of the Rheumatic Diseases conference-abstract Medicine Systemic Lupus Erythematosus Research Open access
Y K Onno Teng, André van Maurik, N. L. Fox, Y Irene Gregan, James Groark, Josephine C Ocran-Appiah, +4 more
3citations -
Efficacité et tolérance du traitement séquentiel belimumab (BEL) sous-cutané et rituximab (RTX) chez des patients atteints de lupus systémique (LS) : étude BLISS-BELIEVE de phase 3, randomisée, contrôlée versus placebo
Zahir Amoura, C. Aranow, C. Allaart, IN Bruce, Patricia C. Cagnoli, R. Furie, +14 more
0citations -
EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update2025 Annals of the Rheumatic Diseases article Medicine Systemic Lupus Erythematosus Research Open access
Antonis Fanouriakis, Myrto Kostopoulou, Hans‐Joachim Anders, Jeanette Andersen, Martin Aringer, Michael William Beresford, +23 more
105citations -
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update2023 Annals of the Rheumatic Diseases article Medicine Systemic Lupus Erythematosus Research Open access
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Martin Aringer, Laurent Arnaud, Sang‐Cheol Bae, +36 more
1,076citations -
2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis2020 Annals of the Rheumatic Diseases article Medicine Systemic Lupus Erythematosus Research Open access cited by 7 patents
Antonis Fanouriakis, Myrto Kostopoulou, Kim Cheema, Hans‐Joachim Anders, Martin Aringer, Ingeborg M. Bajema, +21 more
833citations -
OP0163 2019 UPDATE OF THE JOINT EUROPEAN LEAGUE AGAINST RHEUMATISM AND EUROPEAN RENAL ASSOCIATION–EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE MANAGEMENT OF LUPUS NEPHRITIS2020 Annals of the Rheumatic Diseases article Medicine Systemic Lupus Erythematosus Research Open access
Antonis Fanouriakis, Myrto Kostopoulou, K. Cheema, H. J. Anders, Martin Aringer, Ingeborg M. Bajema, +21 more
7citations -
EULAR 2023 recommendations for SLE treatment: synopsis for the management of lupus nephritis: the European Renal Association–Immunonephrology Working Group (ERA-IWG) perspective
Eleni A. Frangou, Annette N. Bruchfeld, Gema Maria Fernandez Juarez, Jürgen Floege, Dimitrios S. Goumenos, Sarah Margaret Moran, +4 more
10citations
21 results